Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece.
Chatzilygeroudi T, Darmani I, El Gkotmi N, Vryttia P, Douna S, Bouchla A, Labropoulou V, Kotsopoulou M, Symeonidis A, Pagoni M, Pappa V, Papageorgiou SG. Chatzilygeroudi T, et al. Among authors: papageorgiou sg. J Clin Med. 2024 Jan 19;13(2):584. doi: 10.3390/jcm13020584. J Clin Med. 2024. PMID: 38276092 Free PMC article.
Primary Adrenal Lymphomas with Cushing's Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells.
Papageorgiou SG, Mavroeidi I, Kostakis M, Spathis A, Leventakou D, Kritikou E, Oikonomopoulos N, Kourkouti C, Krania M, Bouchla A, Thomopoulos T, Tsakiraki Z, Markakis K, Panayiotides IG, Thomaidis N, Pappa V, Foukas PG, Peppa M. Papageorgiou SG, et al. J Clin Med. 2023 Jul 31;12(15):5032. doi: 10.3390/jcm12155032. J Clin Med. 2023. PMID: 37568434 Free PMC article.
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
Diamantopoulos PT, Pappa V, Symeonidis A, Kotsianidis I, Galanopoulos A, Papadaki H, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Kotsopoulou M, Repousis P, Dimou M, Solomou E, Pontikoglou C, Kyriakakis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kourakli A, Panayiotidis P, Viniou NA. Diamantopoulos PT, et al. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):114-121. doi: 10.1016/j.clml.2019.09.614. Epub 2019 Sep 28. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31884152
Chronic myelomonocytic leukemia - a review.
Thomopoulos TP, Bouhla A, Papageorgiou SG, Pappa V. Thomopoulos TP, et al. Among authors: papageorgiou sg. Expert Rev Hematol. 2021 Jan;14(1):59-77. doi: 10.1080/17474086.2021.1860004. Epub 2020 Dec 12. Expert Rev Hematol. 2021. PMID: 33275852 Review.
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group.
Mpakou V, Spathis A, Bouchla A, Tsakiraki Z, Kontsioti F, Papageorgiou S, Bazani E, Gkontopoulos K, Thomopoulos T, Glezou I, Galanopoulos A, Symeonidis A, Diamantopoulos PT, Viniou NA, Kontandreopoulou CN, Zafeiropoulou K, Kotsianidis I, Lamprianidou E, Foukas P, Mpamias A, Pappa V. Mpakou V, et al. Hematol Oncol. 2021 Apr;39(2):231-242. doi: 10.1002/hon.2834. Epub 2021 Jan 1. Hematol Oncol. 2021. PMID: 33332639
Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes.
Gardikas N, Vikentiou M, Konsta E, Kontos CK, Papageorgiou SG, Spathis A, Bazani E, Bouchla A, Kapsimali V, Psarra K, Foukas P, Dimitriadis G, Pappa V. Gardikas N, et al. Among authors: papageorgiou sg. Cytometry B Clin Cytom. 2019 Jan;96(1):73-82. doi: 10.1002/cyto.b.21725. Epub 2018 Oct 17. Cytometry B Clin Cytom. 2019. PMID: 30334347 Free article.
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.
Diamantopoulos P, Koumbi D, Kotsianidis I, Pappa V, Symeonidis A, Galanopoulos A, Zikos P, Papadaki HA, Panayiotidis P, Dimou M, Hatzimichael E, Vassilopoulos G, Delimpasis S, Mparmparousi D, Papageorgiou S, Variami E, Kyrtsonis MC, Megalakaki A, Kotsopoulou M, Repousis P, Adamopoulos I, Kontopidou F, Christoulas D, Kourakli A, Tsokanas D, Konstantinos Papoutselis M, Kyriakakis G, Viniou NA; Hellenic MDS study group. Diamantopoulos P, et al. Cancer Med. 2019 May;8(5):2056-2063. doi: 10.1002/cam4.2090. Epub 2019 Mar 21. Cancer Med. 2019. PMID: 30897290 Free PMC article.
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Diamantopoulos PT, Symeonidis A, Pappa V, Kotsianidis I, Galanopoulos A, Pontikoglou C, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Repousis P, Kotsopoulou M, Dimou M, Solomou E, Dryllis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kyrtshonis MC, Kourakli A, Papadaki H, Panayiotidis P, Viniou NA. Diamantopoulos PT, et al. Br J Haematol. 2021 Mar;192(6):978-987. doi: 10.1111/bjh.17062. Epub 2020 Aug 30. Br J Haematol. 2021. PMID: 32862447 Free article.
Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report.
Papageorgiou SG, Divane A, Roumelioti M, Kottaridi C, Bouchla A, Georgakopoulos A, Ieremiadou F, Daraki A, Bazani E, Thomopoulos TP, Chatziioannou S, Mavrogenis A, Panayiotidis P, Panayiotides IG, Pappa V, Foukas PG. Papageorgiou SG, et al. Onco Targets Ther. 2020 Nov 16;13:11689-11695. doi: 10.2147/OTT.S276497. eCollection 2020. Onco Targets Ther. 2020. PMID: 33235460 Free PMC article.
247 results